ST.27-legal status data

The legal status information displayed below is based on WIPO Standard ST.27 and of a purely informative nature. Binding information on the status of the IP right is only available in DPMAregister (Show details).

DE file number: 60 2015 073 240.5, EP file number: 19 19 9101.7 (Designation/title: NEUARTIGE PEPTIDE UND KOMBINATION VON PEPTIDEN ZUR VERWENDUNG IN DER IMMUNTHERAPIE GEGEN HEPATOZELLULÄRES KARZINOM (HCC) UND ANDERE KREBSARTEN)

↩ Details

Tabular representation
Current state: Not active, Current state: Termination likely/termination

Key event history
No. Key Event Code Key Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q10 Document published Mar 25, 2020Mar 25, 2020 Filing
2 Q10 Document published May 7, 2020May 7, 2020May 7, 2020 Filing
3 Q10 Document published Sep 8, 2021Sep 8, 2021 Examination
4 Q10 Document published Sep 30, 2021Sep 30, 2021Sep 30, 2021 Examination
5 F10 IP right granted Jun 9, 2022Jun 9, 2022Sep 1, 2022 Grant
6 H10 IP right ceased Jul 2, 2024Jul 2, 2024Sep 26, 2024 Termination likely/termination
Detailed event history
No. Detailed Event Code Detailed Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q12 Application published Mar 25, 2020Mar 25, 2020 Filing
2 Q10 Document published May 7, 2020May 7, 2020May 7, 2020 Filing
3 Q10 Document published Sep 8, 2021Sep 8, 2021 Examination
4 Q10 Document published Sep 30, 2021Sep 30, 2021Sep 30, 2021 Examination
5 F10 IP right granted Jun 9, 2022Jun 9, 2022Sep 1, 2022 Grant
6 H13 IP right lapsed Jul 2, 2024Jul 2, 2024Sep 26, 2024 Termination likely/termination

Graphical representation

Below you will see a simplified graphical representation of the legal status information, which is based on WIPO Standard ST.27 using the "Overall Patent/SPC Prosecution Model" defined therein.

Graphical representation of the ST.27 legal status data